Monoclonal antibody biosimilars

descriptionPublicationkeyboard_double_arrow_right Article 18 Dec 2015 English Publisher:Springer Science and Business Media LLCJournal:Nature Reviews Drug Discovery, volume 15, pages 13-14 (issn: 1474-1776, eissn: 1474-1784,

Copyright policy )

Authors: Natasha, Udpa; Ryan P, Million;

doi: 10.1038/nrd.2015.12

pmid: 26678619

Monoclonal antibody biosimilars

- Summary
- Subjects
- Metrics

Abstract

With biosimilar monoclonal antibodies now entering the market and a surge of biosimilars expected once the patents for major pioneer products expire, this article analyses experiences so far and future market dynamics.

Keywords

Antibodies, Monoclonal, Humans, Biosimilar Pharmaceuticals

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	36
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Top 10%
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Top 10%
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Top 10%